Category Archives: News

Clarity licenses technology from Baker IDI that can be used to detect vulnerable, rupture-prone plaque

Sydney, Australia, 8 April 2015 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, has signed a licensing agreement with  Baker IDI Heart and Diabetes Institute (Melbourne, Australia) to develop a diagnostic for the detection of rupture-prone plaque. The importance of detecting unstable, rupture-prone plaque, especially to prevent recurrent heart attacks,…

Eminent Physicist joins Clarity Pharmaceuticals

Professor Dale Bailey brings link to Translational Cancer Centre Sydney, Australia, 18 Dec 2014 – Sydney based biotech company Clarity Pharmaceuticals is pleased to announce that Professor Dale Bailey from PharmaScint, a specialist clinical trials imaging and analysis organization, has joined their expert scientific advisory group. In addition to being a Director of PharmScint, Professor…

Media Release: Clarity Pharmaceuticals raises $1.1 million

1 May 2014 Oversubscribed Aussie startup set to deliver new personalised medicine Sydney, Australia, 1 May 2014 – Sydney based biotech startup Clarity Pharmaceuticals has raised $1.1 million from investors to expand its international operations in the US, Europe and Asia and to develop new personalised medicine applications for their proprietary pharmaceutical imaging technology. Sydney…

New Executive Chairman

18 November 2013   Clarity Pharmaceuticals (Clarity), a Sydney-based companion diagnostic and personalised medicine company, is pleased to announce the appointment of Dr Alan Taylor as its new Executive Chairman to the Board. Dr Taylor has a background in both investment banking and medical science, and brings a wealth of experience to the Clarity Board.…

Clarity Pharmaceuticals awarded $300,000 in Commercialisation Australia Grant funding

5 December 2011 Clarity Pharmaceuticals has been awarded two Commercialisation Australia grants totalling $300,000.  The “Skills and Knowledge” and “Proof of Concept” grants will help Clarity provide its PET imaging agents and services for human clinical studies, and aid in Clarity’s diagnostic development program.  The funding will directly contribute to a clinical trial validating one…

University of Melbourne awarded ARC Linkage Grant with Clarity Pharmaceuticals

November 2011 Dr Paul Donnelly has been awarded an ARC Linkage grant worth over $500,000, with Clarity Pharmaceuticals as an industry partner.  Dr Donnelly is a Senior Lecturer of the School of Chemistry at the University of Melbourne and a member of the Bio21 Institute, whose vision is to “improve health and the environment through…